Recommended

GSK appoints new CEO
New webinar | Addressing the time-to-result challenge posed by short shelf-life radiopharmaceuticals, register today
Genmab acquires biotech Merus for $8bn
US FDA licensing first for IL-23 inhibitor to treat paediatric psoriasis
Teva makes progress on API business divestment
Takeda to move away from cell therapy
article

Establishing a new pharmaceutical track and trace system in Dubai

66
SHARES

Health authorities in Dubai have announced that they will introduce a new track and trace system to the emirate by mid-2020. This article investigates how this will help to improve the safety and quality of medicinal products.

One way to reduce the number of counterfeit or substandard drugs in the supply chain is to use a track and trace system. This allows a medicinal product to contain information about its origin and be located within the supply chain.1 

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

A new tracking system is expected to be launched in Dubai, UAE later this year2 that will enable the Dubai Health Authority (DHA) to monitor medicines and hopefully improve patient safety. In other countries, traceability schemes similar to the developments in Dubai highlight the progresses made worldwide to reduce the frequency of poor-quality drugs.

Monitoring medicines

Track and trace systems enable authorities and those working within the supply chain to identify where specific medicines are. This includes a drug’s current and previous locations. 

The data is typically relevant to the batch/lot level and uses a manufacturing batch or serial number to categorise the products.1 This is usually present on the packaging of medicines. However, one limit to this type of traceability system is that individual products can be removed from their larger batch, providing uncertainty as to their specific location in the supply chain.

This challenge can be negated by individual packet serialisation, meaning single units have their own serial numbers to specify where they have been. Identification can therefore be placed at the batch level, on pallets and packs, on the outer packing of products and on the immediate packaging of medicines.1 

One advantage of implementing track and trace processes into pharmaceutical supply chains is the reduction of counterfeit medicines. Last year saw the Dubai government consider new laws to fine those caught selling counterfeit drugs up to Dh1 million along with a five-year prison sentence,3 demonstrating the nation’s aim to reduce the danger of substandard drugs. 

Other benefits to a formal track and trace scheme include improved product recalls and better logistic management, among others, as authorities can reveal more about products before they reach patients.

Measures in Dubai

Authorities in Dubai intend to use a track and trace policy to improve their management of the pharmaceutical supply chain by mid-2020.

The new system will be implemented for medicines that have been manufactured in the UAE as well as foreign products.2 According to reports, the DHA will be the first national health authority in the UAE to adopt such a process. 

In 2017, the DHA introduced a barcode labelling system in the emirate, which the new track and trace information will support. The barcodes are based on a GS1 data matrix encoding a medicine’s Global Trade Identifier Number (GTIN), expiration date and batch or lot number.4 The new policy will aid the regulatory body by including medicines from oversees as well as from the UAE. It will also affect the whole supply chain; from the manufacturing stage to the patient level.

Another benefit that the new system will provide is to aid in the prevention of drug shortages.5 Gaining more knowledge about the supply chain can help authorities identify where problems may lie, in order to address them. Also, as both UAE medicines and imported products can be classified, it may enable the DHA to find weaknesses in the supply chain by locating where disruptions originate. 

In a statement, Dr Ali Al Sayed, the Director of the Pharmaceutical Services Department at the DHA, said the regulatory body works constantly on developing its pharmaceutical services to provide quality products to patients and achieve customer satisfaction.

…benefits to a formal track and trace scheme include improved product recalls and better logistic management”

He added that the authority has a clear plan to continue adopting the latest systems, which should keep their supply chain management as up to date as possible.6 

Although in its early inception, Dubai will soon see the policy rolled out, with the aim to improve the authenticity of products within the pharmaceutical supply chain. 

The future for track and trace

According to reports, the DHA is already in talks with manufacturing and pharmaceutical companies to implement their track and trace system, indicating that the future for pharmaceutical monitoring is evolving quickly. 

The market for trace and trace solutions appears to be growing at a global scale, with research predicting it to be worth over $7 billion by 2026. The compound annual growth rate (CAGR) is also expected to grow by nearly 20 percent in the next six years.

Another area of the world where traceability systems are being utilised is India. Two-dimensional (2D) barcodes on pharmaceutical packaging will reportedly soon be mandatory in the country, which will contain information such as manufacturer location and batch number and can be read using software.8 During manufacture, a unique code is entered into a network that enables each product to be authenticated, meaning that the frequency of counterfeit drugs should be reduced. 

A similar system is present in the US, where the Drug Supply Chain Security Act (DSCSA) outlines steps to improve the traceability of medicines in the country. In February 2019, the Food and Drug Administration (FDA) announced that a DSCSA Pilot Project Program will develop an electronic, interoperable network to identify and trace drugs.9 The DSCSA also established national licensure standards for wholesale distributors and third-party logistics providers, which requires these organisations to report licensure and other information to the FDA annually, improving the regulatory body’s management even further.

Many countries around the world are therefore seeing the advantages of track and trace systems for the pharmaceutical industry, to ensure that the drugs provided to patients are safe. Other processes and reports can also be further implemented such as licensure standards, to gain even more insight into the industry.

Summary

Track and trace systems ensure the pharmaceutical supply chain is as secure as possible by providing information about the origin and locations of certain products. This allows regulatory bodies to govern the safe distribution of drugs by reducing the number of counterfeit medicines, making recalls easier and improving logistic management.

Dubai’s new process will enable the country’s regulatory body to effectively oversee the entire pharmaceutical supply chain and detect any issues that may arise. In a similar fashion to India and the US, the new system should afford Dubai the assurance of improved drug quality. 

References

  1. [Internet]. Who.int. 2020 [cited 9 January 2020]. Available from: https://www.who.int/medicines/regulation/ssffc/mechanism/A69_41-en9-28.pdf
  2. Dubai’s medicine tracking system to tackle counterfeit drugs [Internet]. The National. 2020 [cited 9 January 2020]. Available from: https://www.thenational.ae/uae/health/dubai-s-medicine-tracking-system-to-tackle-counterfeit-drugs-1.955648
  3. UAE government considers tough new laws to tackle scourge of fake medicine [Internet]. The National. 2020 [cited 9 January 2020]. Available from: https://www.thenational.ae/uae/health/uae-government-considers-tough-new-laws-to-tackle-scourge-of-fake-medicine-1.838940
  4. Dubai pledges to roll out track-and-trace for drugs in 2020 [Internet]. Securingindustry.com. 2020 [cited 9 January 2020]. Available from: https://www.securingindustry.com/pharmaceuticals/dubai-pledges-to-roll-out-track-and-trace-for-drugs-in-2020/s40/a11141/#.Xg8wB0f7S70
  5. Dubai Health Authority to implement new medication tracking system in mid-2020 [Internet]. ArabianBusiness.com. 2020 [cited 9 January 2020]. Available from: https://www.arabianbusiness.com/technology/436172-dubais-dha-to-implement-new-medication-tracking-system-in-mid-2020
  6. DHA adopts “Track and Trace” system to monitor medications and ensure patient safety [Internet]. Zawya.com. 2020 [cited 9 January 2020]. Available from: https://www.zawya.com…
  7. The Track and Trace Solutions Market Garner Growth 18% – Media Releases – CSO | The Resource for Data Security Executives [Internet]. Www2.cso.com.au. 2020 [cited 9 January 2020]. Available from: https://www2.cso.com.au/mediareleases/37134/the-track-and-trace-solutions-market-garner/
  8. India to Track API Packs [Internet]. Contract Pharma. 2020 [cited 9 January 2020]. Available from: https://www.contractpharma.com/issues/2019-11-01/view_india-report/india-to-track-api-packs/
  9. DSCSA pilot project program: how to participate [Internet]. U.S. Food and Drug Administration. 2020 [cited 9 January 2020]. Available from: https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/dscsa-pilot-project-program
Share via
Share via